Vaxigrip suspension for injection in pre-filled syringe
*Company:
Sanofi PasteurStatus:
NewLegal Category:
Product subject to medical prescription which may be renewed (B)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 08 July 2025
File name
314 Vaxigrip TIV - IE - PIL text - ASV NH2025-26.pdf
Reasons for updating
- Change to section 6 - date of revision
Updated on 08 July 2025
File name
314 Vaxigrip TIV - IE - SmPC - ASV NH2025-26 - 25Jun25 (1).pdf
Reasons for updating
- Change to section 2 - Qualitative and quantitative composition
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 10 April 2025
File name
314 Vaxigrip TIV - IE - SmPC - Immunity Persistence - clean.pdf
Reasons for updating
- Change to section 5.1 - Pharmacodynamic properties
- Change to section 6.4 - Special precautions for storage
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 26 March 2025
File name
314 - Vaxigrip TIV - IE - PIL text - clean - DEHxxxxIA1132G.pdf
Reasons for updating
- New PIL for new product
Updated on 26 March 2025
File name
314 Vaxigrip TIV - IE SmPC clean.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may be renewed (B)
Sanofi Pasteur
Address:
Citywest Business Campus, Dublin 24, IrelandMedical Information E-mail:
iemedinfo@sanofi.comTelephone:
+353 (0)1 403 5600